Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus

NCT06148649 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

234

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: HEC88473, Placebo, Dulaglutide

Sponsor

Dongguan HEC Biopharmaceutical R&D Co., Ltd.